Table 5.
Complications | p-Value | Complication | ||
---|---|---|---|---|
Source | RCA | Heparin | ||
Sik et al., 2019 [15] | 7.01% | 6.41% | 0.956 | Metabolic alkalosis |
12.28% | 2.56% | <0.05 | Hypocalcemia | |
14.03% | 10.25% | <0.05 | Hypernatremia | |
0.8 [0.3–2.0] | 1.65 [0.5–2.38] | 0.32 | Units of RBC transfused | |
Rico et al., 2017 [18] | 30% | 32.6% | 0.605 | Severe bleeding events |
Raymakers-Janssen et al., 2017 [19] | 3 [2.0–5.0] | 6.5 [1.5–23.8] | 0.12 | Units of RBC transfused |
Zaoral et al., 2016 [20] | 0.17 [0.0–1.0] | 0.36 [0.0–2.0] | 0.003 | Units of RBC transfused |
Fernandez et al., 2014 [21] | 45.5% | 0% | <0.01 | Hypochloremia |
27.3% | 0% | 0.045 | Hypomagnesemia | |
0% | 27.8 | 0.06 | Hypophosphatemia | |
Soltysiak et al., 2014 [22] | 18.75% | 0% | N/A | Hyponatremia |
Soltysiak et al., 2014 [22] | 18.75% | 14.3% | N/A | Hypernatremia |
12.5% | 21.4% | N/A | Hyperkalemia | |
62.5% | 28.6% | N/A | Hypokalemia | |
43.75% | 64.3% | N/A | Hypercalcemia | |
43.75% | 0% | N/A | Hypocalcemia | |
43.75% | 42.9% | N/A | Metabolic acidosis | |
25% | 14.3% | N/A | Metabolic alkalosis |